Method for preparing whole bovine-derived broadly neutralizing antibody against serotype O foot-and-mouth disease virus

A method for preparing a whole bovine-derived broadly neutralizing antibody against serotype O foot-and-mouth disease virus, comprising the following steps:

• 1) conducting a first immunization on a cattle by using a serotype O foot-and-mouth disease virus, conducting a second immunization within 30-60 days after the first immunization, and conducting a third immunization within 120-150 days after the first immunization;
• wherein the Serotype O foot-and-mouth disease virus comprises the following three topotypes:
• a virus strain of South-East Asia topotype, a virus strain of Middle East-South Asia topotype, and a virus strain of Cathay topotype;
• and the serotype O foot-and-mouth disease viruses employed in the first immunization, the second immunization and the third immunization are of viruses from different topotypes;
• 2) after the third immunization, isolating a peripheral blood mononuclear cell, and screening for serotype O foot-and-mouth disease virus antigen-specific single B cells by using a bait antigen;
• wherein the bait antigen comprises serotype O foot-and-mouth disease virus labeled by biotin or a fluorescent protein;
• and wherein the bait antigen is a 146S antigen;
• 3) using the cDNA of the serotype O foot-and-mouth disease virus antigen-specific single B cell obtained in step 2) as a template to amplify variable region genes of heavy and light chains of the bovine antibody;
• wherein the amplification comprises a nested PCR amplification method, and the primers used in the nested PCR amplification comprise:
• an IgG variable region outer primer pair, an IgG variable region inner primer pair, an IgM variable region outer primer pair, an IgM variable region inner primer pair, an IgD variable region outer primer pair, an IgD variable region inner primer pair, an Ig lambda outer primer pair, and an Ig lambda inner primer pair;
• where the upstream primer of each of the IgG variable region outer primer pair, the IgM variable region outer primer pair and the IgD variable region outer primer pair are identical and have the sequence of SEQ ID NO. 1, and the downstream primers of the IgG variable region outer primer pair, the IgM variable region outer primer pair and the IgD variable region outer primer pair have the sequences of SEQ ID NO. 2, SEQ ID NO. 3 and SEQ ID NO. 4 respectively;
• the upstream primer of each of the IgG variable region inner primer pair, the IgM variable region inner primer pair and the IgD variable region inner primer pair are identical and have the sequence of SEQ ID NO. 5, and the downstream primers of the IgG variable region inner primer pair, the IgM variable region inner primer pair and the IgD variable region inner primer pair have the sequences of SEQ ID NO. 6, SEQ ID NO. 7 and SEQ ID NO. 8 respectively;
• the nucleotide sequences of the Ig lambda outer primer pair are the sequences of SEQ ID NO. 9 and SEQ ID NO. 10;
• and
• the nucleotide sequences of the Ig lambda inner primer pair are the sequences of SEQ ID NO. 11 and SEQ ID NO. 12;
• 4) using the total cDNA of the bovine peripheral blood mononuclear cell as a template to amplify the full-length sequences of the heavy and light chains of the bovine antibody, thereby obtaining constant region sequences of the heavy and light chains of the bovine antibody;
• the amplification comprises a method of rapid amplification of cDNA ends, and the primers used for the rapid amplification of cDNA ends comprise:
• an IgG heavy chain 5′ rapid amplification of cDNA end primer with the nucleotide sequence of SEQ ID NO. 13, an IgG heavy chain 3′ rapid amplification of cDNA end primer with the nucleotide sequence of SEQ ID NO. 14, an IgG Lambda light chain 5′ rapid amplification of cDNA end primer with the nucleotide sequence of SEQ ID NO. 15, an IgG Lambda light chain 3′ rapid amplification of cDNA end primer with the nucleotide sequence of SEQ. ID NO. 16, an IgG Kappa light chain 5′ rapid amplification of cDNA end primer with the nucleotide sequence of SEQ ID NO. 17, and an IgG Kappa light chain 3′ rapid amplification of cDNA end primer with the nucleotide sequence of SEQ ID NO. 18;
• 5) constructing the heavy chain variable region gene of the bovine antibody obtained in step 3) and the heavy chain constant region sequence of the bovine antibody obtained in step 4) into an expression vector to obtain a full-length heavy chain vector of the whole bovine-derived monoclonal antibody;
• and constructing the light chain variable region gene of the bovine antibody obtained in step 3) and the light chain constant region sequence of the bovine antibody obtained in step 4) into an expression vector to obtain a full-length light chain vector of the whole bovine-derived monoclonal antibody;
• and
• 6) mixing the full-length heavy chain vector of the whole bovine-derived monoclonal antibody and the full-length light chain vector of the whole bovine-derived monoclonal antibody obtained in step 5) at a mass ratio of 1:(1-3) to co-transfect a cell, taking a supernatant after culture of the transfected cells, and purifying to obtain a whole bovine-derived broadly neutralizing antibody against the serotype O foot-and-mouth disease virus;
• wherein there is no limitation in the order of steps 3) and 4).